Expressing support for the designation of May as "National Asthma and Allergy Awareness Month".

Bill: 116-hres-957
Sponsor: full_name: Rep. Engel, Eliot L. [D-NY-16]
Introduced: 2020-05-08
Policy area: Health
Subjects: Allergies

Cardiovascular and respiratory health

Commemorative events and holidays

Congressional tributes

Health information and medical records

Health personnel

Medical research
Latest action: action_date: 2020-05-08
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2020-05-08
action_desc: Introduced in House
text: <p>This resolution expresses support for (1) the designation of National Asthma and Allergy Awareness Month, and (2) investment in asthma research.</p> <p>It also salutes health care professionals and researchers who work on asthma and allergies.</p>

tv_txt: IV 116th CONGRESS 2d Session H. RES. 957 IN THE HOUSE OF REPRESENTATIVES May 8, 2020 Mr. Engel (for himself, Mr. Upton , Mr. Cox of California , and Mr. King of New York ) submitted the following resolution; which was referred to the Committee on Energy and Commerce RESOLUTION Expressing support for the designation of May as National Asthma and Allergy Awareness Month .

Whereas 5,500,000 children in the United States, 7.5 percent, currently have asthma; Whereas 24,800,000, or one in 13 people in the United States, have asthma and the numbers are increasing each year; Whereas, in 2018, on average, children missed more than 7,900,000 days of school and adults missed 10,900,000 days of work because of asthma; Whereas asthma is the second most common noncommunicable disease among children; Whereas 1,700,000 individuals per year visit emergency departments because of asthma’s effects; Whereas the total economic cost of asthma in the United States was $81,900,000,000 per year from 2008 to 2013; Whereas fewer than half of people with asthma report being given an asthma action plan, which is key to the prevention of asthma attacks; Whereas asthma is a manageable disease; Whereas those with moderate to severe asthma may be at a greater risk of developing serious complications as a result of COVID–19 during the current public health emergency; and Whereas May would be an appropriate month to designate as National Asthma and Allergy Awareness Month : Now, therefore, be it

That the House of Representatives— (1) supports the designation of National Asthma and Allergy Awareness Month ; (2) encourages awareness of the prevalence of asthma and allergies, including heightened prevalence among women, minority, and urban demographics; (3) recognizes and salutes health care professionals who treat asthma and allergy-related health issues; (4) recognizes and salutes researchers working to identify asthma and allergy cures; (5) recognizes and reaffirms commitment to public education about asthma and allergy treatment and symptoms and to advancing care for both asthma and allergy conditions; and (6) supports investment in researching the prevention, treatment, and eradication of asthma.